We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Stevanato
STVN
$5.37B
| – | – |
-15,207
| Closed | -$305K |
|
|
SWTX
3802
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-704,597
| Closed | -$39.8M |
|
3803
Symbotic
SYM
$5.11B
| – | – |
-618,363
| Closed | -$6.13M |
|
3804
Spyre Therapeutics
SYRE
$8.87B
| – | – |
-6,167
| Closed | -$355K |
|
3805
TAL Education Group
TAL
$5.71B
| – | – |
-746,705
| Closed | -$2.25M |
|
3806
Invesco Solar ETF
TAN
$1.47B
| – | – |
-9,299
| Closed | -$701K |
|
3807
Molson Coors Class B
TAP
$7.68B
| – | – |
-6,116
| Closed | -$327K |
|
3808
TaskUs
TASK
$506M
| – | – |
-235,564
| Closed | -$9.06M |
|
3809
Teledyne Technologies
TDY
$30.4B
| – | – |
-77,818
| Closed | -$36.8M |
|
3810
TE Connectivity
TEL
$58.8B
| – | – |
-102,211
| Closed | -$13.4M |
|
3811
Teradyne
TER
$54.8B
| – | – |
-484,671
| Closed | -$57.3M |
|
|
3812
Teleflex
TFX
$5.85B
| – | – |
-678,751
| Closed | -$241M |
|
|
TGI
3813
DELISTED
Triumph Group
TGI
| – | – |
-16,666
| Closed | -$421K |
|
3814
Gentherm
THRM
$1.31B
| – | – |
-7,381
| Closed | -$539K |
|
|
TIGR
3815
UP Fintech Holding
TIGR
$845M
| – | – |
-100,567
| Closed | -$493K |
|
3816
Titan Machinery
TITN
$466M
| – | – |
-20,386
| Closed | -$577K |
|
3817
TJX Companies
TJX
$170B
| – | – |
-57,368
| Closed | -$3.48M |
|
3818
Tandem Diabetes Care
TNDM
$1.17B
| – | – |
-24,703
| Closed | -$2.87M |
|
3819
TriNet
TNET
$2.84B
| – | – |
-23,844
| Closed | -$2.35M |
|
3820
Tango Therapeutics
TNGX
$4.34B
| – | – |
-28,915
| Closed | -$220K |
|
3821
Teekay Tankers
TNK
$2.63B
| – | – |
-97,838
| Closed | -$1.35M |
|
3822
Kartoon Studios
TOON
$34.3M
| – | – |
-3,695
| Closed | -$38K |
|
3823
Toast
TOST
$16.8B
| – | – |
-177,440
| Closed | -$3.86M |
|
3824
TPG
TPG
$6.87B
| – | – |
-7,064
| Closed | -$213K |
|
|
TPH
3825
DELISTED
Tri Pointe Homes
TPH
| – | – |
-38,396
| Closed | -$771K |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.